CareDx, Inc. (CDNA) Financials
CDNA Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 484.6 million | 223.3 million |
| 2023-09-30 | 501.2 million | 107.0 million |
| 2023-06-30 | 514.8 million | 109.6 million |
| 2023-03-31 | 528.2 million | 108.2 million |
CDNA Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | -10.0 million | 10.0 million |
| 2023-09-30 | -12.7 million | 12.7 million |
| 2023-06-30 | -2.9 million | 12.7 million |
| 2023-03-31 | -2.1 million | 13.8 million |
CDNA Net Income
No data available :(
CDNA Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 235.4 million | - | 34.2 million |
| 2023-09-30 | 268.2 million | - | 35.2 million |
| 2023-06-30 | 282.7 million | - | 36.4 million |
| 2023-03-31 | 285.9 million | - | 32.0 million |
CDNA Shares Outstanding
CDNA Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 1.6 million | 18.3 million | 26.5 million | 20.0 million |
| 2023-09-30 | 2.5 million | 19.0 million | 34.0 million | 18.5 million |
| 2023-06-30 | 2.4 million | 20.2 million | 29.3 million | 21.6 million |
| 2023-03-31 | 2.8 million | 24.4 million | 28.0 million | 23.2 million |
CDNA Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 65.6 million | 26.3 million |
| 2023-09-30 | 67.2 million | 24.5 million |
| 2023-06-30 | 70.3 million | 25.9 million |
| 2023-03-31 | 77.3 million | 26.0 million |
CDNA
Price: $9.72
52 week price:
Earnings Per Share: -3.54 USD
P/E Ratio: -5.07
Exchange: NGM
Sector: Healthcare
Industry: Diagnostics & Research
Volume: 944000
Ebitda: -11.9 millionMarket Capitalization: 519.9 million